Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN114751937B reveals a novel Friedel-Crafts route for Baryphos intermediate. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel FeCl3-catalyzed route offers high yield and scalability for drug intermediates, reducing costs in API manufacturing.
Patent CN111423381B reveals a mild Pd-catalyzed route to 2-trifluoromethyl imidazoles, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Novel palladium-catalyzed route offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing with scalable processes.
Novel nickel-catalyzed method offers cost-effective supply chain solutions for high-purity intermediates without noble metals.
Novel synthesis method for N-N axis chiral compounds offers high enantioselectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN109879792B details a Rh(III)-catalyzed oxidative Heck reaction for isoindoles. Offers efficient route for pharmaceutical intermediates manufacturing with improved atom economy.
Patent CN115215810B reveals a metal-free heating method for 5-trifluoromethyl-1,2,4-triazoles, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Discover a novel nickel-catalyzed method for synthesizing alpha,beta-unsaturated thioesters using arylsulfonyl chlorides. A cost-effective, scalable solution for pharma intermediates.
Patent CN104447396B details a novel Pd-catalyzed route for benzoin oxime derivatives, offering safer alternatives to cyanide methods and enhanced supply chain reliability for pharmaceutical intermediates.
Patent CN112194608A details a visible-light promoted synthesis method offering high yields and mild conditions for pharmaceutical intermediates.
Patent CN113105402B reveals a metal-free iodine-promoted synthesis for trifluoromethyl-triazoles, offering significant cost reduction in API manufacturing and scalable production.
Patent CN112480015B reveals a novel one-pot method for synthesizing 2-trifluoromethyl quinazolinones using nitro compounds, offering significant cost reduction and scalability for API manufacturing.
Patent CN113307790B reveals a metal-free oxidative cyclization route for 1,2,4-triazoles. This method offers significant cost reduction in pharmaceutical intermediate manufacturing via simplified processing.
Novel metal-free synthesis of trifluoromethyl 1,2,4-triazines via [3+3] cycloaddition. Cost-effective, scalable route for pharma intermediates.
Patent CN110357842B reveals metal-free synthesis of fluorinated furans. Offers cost-effective, scalable routes for API intermediates with high purity.
Patent CN111423381A details a mild Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering cost-effective manufacturing and high purity for pharmaceutical applications.
Patent CN103242223A details a Pd-catalyzed decarboxylative coupling for 2-pyridyloxydiaryl ketones, offering cost reduction in API manufacturing and scalable production.
Patent CN112694430B reveals a novel Pd-catalyzed bis-carbonylation route for 1,5-dihydro-2H-pyrrole-2-ketones, offering safer CO surrogates and high yields for reliable pharmaceutical intermediate suppliers.
Efficient cobalt-catalyzed C-H activation method for 2-alkoxyindole compounds. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.